Sagimet Biosciences (SGMT) Gains from Investment Securities: 2022-2024
Historic Gains from Investment Securities for Sagimet Biosciences (SGMT) over the last 3 years, with Dec 2024 value amounting to $149,000.
- Sagimet Biosciences' Gains from Investment Securities rose 5000.00% to $49,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $150,000, marking a year-over-year change of. This contributed to the annual value of $149,000 for FY2024, which is 96.03% down from last year.
- Per Sagimet Biosciences' latest filing, its Gains from Investment Securities stood at $149,000 for FY2024, which was down 96.03% from $3.8 million recorded in FY2023.
- In the past 5 years, Sagimet Biosciences' Gains from Investment Securities ranged from a high of $3.8 million in FY2023 and a low of -$3,000 during FY2022.
- For the 3-year period, Sagimet Biosciences' Gains from Investment Securities averaged around $1.3 million, with its median value being $149,000 (2024).
- As far as peak fluctuations go, Sagimet Biosciences' Gains from Investment Securities surged by 125,216.90% in 2023, and later plummeted by 96.03% in 2024.
- Sagimet Biosciences' Gains from Investment Securities (Yearly) stood at -$3,000 in 2022, then spiked by 125,216.90% to $3.8 million in 2023, then tumbled by 96.03% to $149,000 in 2024.